Antimicrobial Agents Practice Questions

Q: Sulphonamide injection causes decrease in folic acid by?

Inhibition through competition with substrate. ***Inhibition through competition with substrate***Sulphonamides are **structural analogs of p-aminobenzoic acid (PABA)**, a substrate crucial for dihydropteroate synthase [1, 2]. They competitively inhibit this enzyme, which synthesizes **dihydrofolic acid**, a precursor to **tetrahydrofolic acid (THF)**, thereby reducing folic acid production in bacteria [1, 2].*Inhibition without competition*This typically refers to **non-competitive inhibition**, where the inhibitor binds to an allosteric site and changes the enzyme's conformation, regardless of substrate concentration. Sulphonamides, however, specifically compete with PABA at the active site of **dihydropteroate synthase**.*Inhibition through a different site*This describes **allosteric inhibition** or non-competitive inhibition, where the inhibitor binds to a site other than the active site. Sulphonamides do not work through an allosteric mechanism; they directly interfere with the binding of PABA at the enzyme's active site.*Inhibition that does not involve the active site*This is another way to describe **non-competitive** or **allosteric inhibition**, where the inhibitor binds elsewhere on the enzyme, altering its function without directly blocking the active site. Sulphonamides' mechanism is distinct, as they closely resemble the natural substrate and directly compete for the active site of **dihydropteroate synthase**.

Q: Which of the following drugs does not inhibit bacterial protein synthesis?

Sulfonamides. ***Sulfonamides*** - Sulfonamides do **NOT** inhibit bacterial protein synthesis; instead, they inhibit **folic acid synthesis**. - They act as **competitive inhibitors** of dihydropteroate synthase, an enzyme involved in the synthesis of dihydrofolic acid. - Folic acid is essential for nucleotide synthesis and DNA replication, making sulfonamides bacteriostatic agents that work through a completely different mechanism than protein synthesis inhibitors. *Aminoglycosides* - Aminoglycosides bind to the **30S ribosomal subunit**, causing misreading of mRNA and premature termination of protein synthesis. - This leads to the production of **abnormal and non-functional proteins**, ultimately killing the bacterial cell. *Chloramphenicol* - Chloramphenicol binds to the **50S ribosomal subunit**, thereby inhibiting the peptidyl transferase enzyme. - This prevents the formation of **peptide bonds** between amino acids, effectively blocking protein elongation. *Clindamycin* - Clindamycin also binds to the **50S ribosomal subunit**, specifically at the P-site. - It interferes with the **translocation step** of protein synthesis, preventing ribosomal movement along the mRNA.

Q: Which of the following drugs is not used for prophylaxis against malaria?

Artesunate. Artesunate - **Artesunate** is a **fast-acting artemisinin derivative primarily used for treating acute malaria infections, especially severe or complicated cases**, and is not recommended for prophylaxis [4]. - Its short half-life and rapid clearance make it unsuitable for preventing malaria, as it would require frequent dosing, which is impractical for long-term prevention. *Doxycycline* - **Doxycycline** is an **antibiotic** that can be used for malaria prophylaxis, particularly in areas with **chloroquine-resistant P. falciparum** [1]. - It works by inhibiting protein synthesis in the parasite and must be taken daily, starting before travel and continuing for a period after returning [1]. *Chloroquine* - **Chloroquine** was historically a cornerstone for malaria prophylaxis due to its effectiveness and low cost, particularly in areas with **sensitive Plasmodium species.** [2] - However, widespread **chloroquine resistance**, especially in **P. falciparum**, has limited its current use for prophylaxis to specific regions where resistance is not prevalent [2]. *Mefloquine* - **Mefloquine** is an **antimalarial drug** commonly used for prophylaxis, especially in areas with **chloroquine-resistant P. falciparum** [2], [3]. - It is known for its convenience of once-weekly dosing but can have significant **neuropsychiatric side effects**, limiting its use in some individuals [3].

Q: What is the primary purpose of administering a multidrug regimen for tuberculosis (TB) treatment?

To prevent the development of drug resistance. ***To prevent the development of drug resistance*** - Using multiple drugs simultaneously targets different bacterial pathways, reducing the likelihood of *Mycobacterium tuberculosis* evolving resistance to any single drug [1] - This strategy ensures that even if a few bacteria are naturally resistant to one drug, other drugs in the regimen will eliminate them [1] - This is the fundamental principle behind multidrug TB therapy as per WHO guidelines *To provide broad-spectrum coverage* - TB treatment uses multiple drugs specifically against *Mycobacterium tuberculosis*, not for broad-spectrum coverage [2] - These regimens are tailored to the known characteristics of TB bacteria, not to cover a wide range of pathogens [2] - The drugs used (rifampicin, isoniazid, pyrazinamide, ethambutol) are relatively specific for mycobacteria [2] *To minimize side effects* - Administering multiple anti-TB drugs actually increases the risk of cumulative side effects due to drug interactions and individual toxicities [3] - Each drug has its own toxicity profile (hepatotoxicity, optic neuritis, hyperuricemia) [3] - While side effects are monitored, minimizing them is not the primary reason for multidrug approach *To ensure treatment adherence* - Treatment adherence refers to the patient's consistent use of prescribed medications, not the number of drugs - A complex multidrug regimen can actually make adherence more challenging - Directly Observed Therapy (DOT) is often needed to improve adherence with multidrug regimens

Q: Which antibiotic is primarily associated with Red man syndrome?

Vancomycin. **Vancomycin** - **Red man syndrome** is a well-known **infusion-related reaction** primarily associated with vancomycin. - It occurs due to the **rapid infusion** of vancomycin, leading to non-immunologic **mast cell degranulation** and histamine release. - Characterized by flushing, pruritus, and erythema of the upper body and face. - **Prevention:** Slow infusion rate (over 60 minutes or longer) and/or premedication with antihistamines. *Polymyxin B* - Polymyxin B is associated with **nephrotoxicity** and **neurotoxicity**, not typically with Red man syndrome. - It can cause **histamine release** leading to flushing and itching, but this is less common and less severe than with vancomycin. *Rifampicin* - Rifampicin is primarily known for causing **orange-red discoloration** of bodily fluids (e.g., urine, tears, sweat) and can cause **hepatotoxicity**, but not Red man syndrome. - It works by inhibiting bacterial **RNA synthesis** and is used to treat tuberculosis and other mycobacterial infections. *Teicoplanin* - Teicoplanin is a **glycopeptide antibiotic** similar to vancomycin, but it has a **significantly lower incidence** of Red man syndrome. - While it can cause some **infusion-related reactions**, they are generally milder and less frequent compared to vancomycin.

Q: In a child admitted with Haemophilus influenzae meningitis, cefotaxime was started instead of ampicillin. Which of the following is the likely reason for this?

H. influenzae strains known to produce Beta lactamase. ***H. influenzae strains known to produce Beta lactamase*** - Many *H. influenzae* strains, particularly in meningitis, produce **beta-lactamase enzymes** that inactivate ampicillin. - **Cefotaxime**, a third-generation cephalosporin, is **stable against beta-lactamases**, making it an effective empirical treatment. *Easier to give* - The route and ease of administration are generally **not the primary factors** in choosing between ampicillin and cefotaxime in a severe infection like meningitis. - Both medications can be administered intravenously, which is standard for meningitis treatment. *It is cheap* - While cost is a consideration in healthcare, **efficacy and clinical outcome** for a life-threatening condition like meningitis take precedence over cost. - Treatment choices are primarily driven by **antimicrobial susceptibility patterns** and patient safety. *H. influenzae strains known to have altered penicillin binding protein* - While **altered penicillin-binding proteins (PBPs)** can lead to resistance in some bacteria (e.g., *Streptococcus pneumoniae*), it is **not the predominant mechanism of resistance** to ampicillin in *H. influenzae*. - **Beta-lactamase production** is the much more common and significant reason for ampicillin resistance in *H. influenzae*.

Q: Which of the following antimalarials is a slow-acting schizonticide?

Pyrimethamine. ***Pyrimethamine***- Pyrimethamine is a **folate antagonist** [1, 2] that acts as a **slow-acting schizonticide** [1, 3], primarily inhibiting dihydrofolate reductase in the parasite [1].- Due to its slow onset [1], it is typically used in combination with other faster-acting antimalarials, such as sulfadoxine, for treatment or prophylaxis [1].*Artemether*- Artemether is an **artemisinin derivative**, known for its **rapid action** and potent effect against all erythrocytic stages of *Plasmodium falciparum*.- It is a **fast-acting schizonticide** that causes widespread damage to parasite membranes and proteins.*Mefloquine*- Mefloquine is an antimalarial drug recognized for its **long half-life** and efficacy against multidrug-resistant *Plasmodium falciparum*.- While effective, it is considered of **intermediate speed** compared to the rapid action of artemisinins or the very slow action of drugs like pyrimethamine.*Quinine*- Quinine is a **fast-acting schizonticide** that is effective against the asexual erythrocytic forms of *Plasmodium* parasites.- Although potent, its use is limited by potential adverse effects such as **cinchonism** and a short half-life requiring frequent dosing.

Q: What is the recommended duration of erythromycin for the treatment of diphtheria?

14 days. ***14 days*** - The recommended duration for **erythromycin** in treating diphtheria is **14 days** to ensure eradication of *Corynebacterium diphtheriae* and prevent toxin production. - This duration helps to eliminate the carrier state and reduce the risk of transmission to others. *3 days* - A 3-day course of antibiotics is **insufficient** for the complete eradication of *Corynebacterium diphtheriae* in diphtheria. - Such a short duration would likely lead to **treatment failure** and persistence of the infection. *7 days* - While 7 days is a common antibiotic duration for some infections, it is generally considered **too short** for diphtheria treatment. - A 7-day course may not fully eliminate the bacteria, potentially leading to **relapse** or a prolonged carrier state. *30 days* - A 30-day course of erythromycin for diphtheria is **unnecessarily long** and could increase the risk of side effects and antibiotic resistance. - The goal is eradication without excessive drug exposure, which 14 days achieves effectively.

Q: Anaerobic bacteria are intrinsically resistant to which of the following antibiotics?

Aminoglycosides (e.g., gentamicin). ***Aminoglycosides (e.g., gentamicin)*** - Anaerobic bacteria lack the **oxygen-dependent transport systems** necessary to take up aminoglycosides into the bacterial cell. - This results in **intrinsic resistance** because the drug cannot reach its intracellular ribosomal target. *Beta-lactams (e.g., penicillin)* - While some anaerobes (like certain *Bacteroides* species) can be resistant to specific beta-lactams due to **beta-lactamase production**, it's not an intrinsic resistance across all anaerobes to all beta-lactams. - Many anaerobes are **susceptible to penicillin**, especially those that do not produce beta-lactamase, or to beta-lactamase inhibitors combination drugs. *Chloramphenicol (broad-spectrum antibiotic)* - Chloramphenicol is effective against many anaerobic bacteria by inhibiting **protein synthesis**. - Anaerobes are generally **susceptible** to chloramphenicol, and it is not an antibiotic to which they are intrinsically resistant. *Metronidazole (used for anaerobic infections)* - Metronidazole is a **prodrug** that requires anaerobic conditions to become activated. - It is highly effective against most obligate anaerobes and is a common choice for treating **anaerobic infections**, indicating susceptibility, not intrinsic resistance.

Q: On chronic use, linezolid leads to which of the following?

Thrombocytopenia. ***Thrombocytopenia*** - **Linezolid** is known to cause **myelosuppression**, particularly **thrombocytopenia**, with prolonged use (typically >2 weeks). - This adverse effect is usually **reversible** upon discontinuation of the drug. - This is the **most characteristic** and **dose-limiting** hematologic toxicity of chronic linezolid therapy. *Deranged LFT* - While **linezolid** can occasionally cause **elevated liver enzymes**, this is a **less common** adverse effect compared to myelosuppression. - **Thrombocytopenia** is far more characteristic of **chronic linezolid use** and is the primary concern requiring monitoring. - Hepatotoxicity with linezolid is typically mild and less dose-limiting than hematologic effects. *Nephrotoxicity* - **Linezolid** is generally considered to have a low risk of **nephrotoxicity** and does not typically cause significant kidney damage. - **Aminoglycosides** or **vancomycin** are examples of antibiotics more commonly associated with nephrotoxic effects. *Ototoxicity* - **Ototoxicity**, characterized by hearing loss or tinnitus, is not a common or recognized side effect of **linezolid** therapy. - This adverse effect is more frequently associated with drugs like **aminoglycosides** or high-dose **loop diuretics**.

Question 1

Sulphonamide injection causes decrease in folic acid by?

Accepted Answer

Inhibition through competition with substrate

Answer

Inhibition without competition

Answer

Inhibition through a different site

Answer

Inhibition that does not involve the active site

Question 2

Which of the following drugs does not inhibit bacterial protein synthesis?

Accepted Answer

Sulfonamides

Answer

Aminoglycosides

Answer

Chloramphenicol

Answer

Clindamycin

Question 3

Which of the following drugs is not used for prophylaxis against malaria?

Accepted Answer

Artesunate

Answer

Doxycycline

Answer

Mefloquine

Answer

Chloroquine

Question 4

What is the primary purpose of administering a multidrug regimen for tuberculosis (TB) treatment?

Accepted Answer

To prevent the development of drug resistance

Answer

To provide broad-spectrum coverage

Answer

To minimize side effects

Answer

To ensure treatment adherence

Question 5

Which antibiotic is primarily associated with Red man syndrome?

Accepted Answer

Vancomycin

Answer

Polymyxin B

Answer

Rifampicin

Answer

Teicoplanin

Question 6

In a child admitted with Haemophilus influenzae meningitis, cefotaxime was started instead of ampicillin. Which of the following is the likely reason for this?

Accepted Answer

H. influenzae strains known to produce Beta lactamase

Answer

It is cheap

Answer

Easier to give

Answer

H. influenzae strains known to have altered penicillin binding protein

Question 7

Which of the following antimalarials is a slow-acting schizonticide?

Accepted Answer

Pyrimethamine

Answer

Artemether

Answer

Mefloquine

Answer

Quinine

Question 8

What is the recommended duration of erythromycin for the treatment of diphtheria?

Accepted Answer

14 days

Answer

3 days

Answer

7 days

Answer

30 days

Question 9

Anaerobic bacteria are intrinsically resistant to which of the following antibiotics?

Accepted Answer

Aminoglycosides (e.g., gentamicin)

Answer

Beta-lactams (e.g., penicillin)

Answer

Chloramphenicol (broad-spectrum antibiotic)

Answer

Metronidazole (used for anaerobic infections)

Question 10

On chronic use, linezolid leads to which of the following?

Accepted Answer

Thrombocytopenia

Answer

Deranged LFT

Answer

Nephrotoxicity

Answer

Ototoxicity

Antimicrobial Agents — MCQs

Antimicrobial Agents — MCQs

On this page

Practice by Chapter

Want unlimited practice?